Biotech investors

Investors in profile

A growing number of investors is interested in the biotechnology sector. Some have already establsihed an impressive life science portfolio, others now see new potential in this area in the wake of the corona pandemic. Recently, the attractiveness of biotechnology for investors has increased noticeably, so that the diversity of the actors is growing. Here is a selection of relevant investors with their financing focus and investment volume.

Bayern Kapital has been Bavaria's venture capital and growth investor for start-ups with innovative technologies in the high-tech sector since 1995.

BioMed Partners is a leading venture capitalist for life sciences companies in Central Europe.

bmp Ventures is a Berlin-based venture capital firm financing early-stage high-growth technology companies.

Coparion is a venture capital fund that exclusively finances German start-ups and young growth companies in the technology sector.

Gimv is a European investment company driving the pioneering sectors of Life Sciences, Consumer, Healthcare, Smart Industries and Sustainable Cities.

Founded in 2015, Leaps by Bayer is Bayer's impact investment arm focused on life sciences investments.

ECBF is the first venture capital fund exclusively focused on the bioeconomy and the circular bioeconomy in Europe.

EVOequity is the corporate investment unit of Hamburg-based biotech company Evotec. It is focusing on attractive early academic spin-offs established within Evotec’s BRIDGE cooperations as well as promising young companies.

Forbion is a leading venture capital firm that works closely with entrepreneurs to build life sciences companies that transform people’s lives.

HTGF is a seed-focused venture capital investor. Investors of the fund are the German Economics Ministry, KfW Capital and more than 30 well-known companies. Life sciences and biotechnology are among the focus areas among others.  

LSP is one of the largest life sciences and health care investment firms in Europe and has been active in this space for more than 30 years.

M Ventures is the strategic, corporate venture capital arm of Merck KGaA, Darmstadt. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck KGaA, Darmstadt, Germany‘s core business areas.

MIG AG is one of the leading German VC investors. Through the MIG Fonds, young companies are provided with the financial strength to establish and finance growth in the high-tech and life science sectors.

TVM Capital is one of the most experienced transatlantic venture capitalists, investing in international life science companies.

Wellington Partners is a leading European venture capital firm investing in early- and growth-stage life science companies.

Stay informed!

We send the BIOTECH Insight Newsletter four times a year. Register now and receive sector-relevant updates regularly by e-mail.